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Mitochondrial oxidative stress 
promotes atrial fibrillation
Wenjun Xie1, *, Gaetano Santulli1, *, Steven R. Reiken1, Qi Yuan1, Brent W. Osborne1,  
Bi-Xing Chen1 & Andrew R. Marks1,2
Oxidative stress has been suggested to play a role in the pathogenesis of atrial fibrillation (AF). 
Indeed, the prevalence of AF increases with age as does oxidative stress. However, the mechanisms 
linking redox state to AF are not well understood. In this study we identify a link between oxidative 
stress and aberrant intracellular Ca2+ release via the type 2 ryanodine receptor (RyR2) that promotes 
AF. We show that RyR2 are oxidized in the atria of patients with chronic AF compared with 
individuals in sinus rhythm. To dissect the molecular mechanism linking RyR2 oxidation to AF we 
used two murine models harboring RyR2 mutations that cause intracellular Ca2+ leak. Mice with 
intracellular Ca2+ leak exhibited increased atrial RyR2 oxidation, mitochondrial dysfunction, reactive 
oxygen species (ROS) production and AF susceptibility. Both genetic inhibition of mitochondrial ROS 
production and pharmacological treatment of RyR2 leakage prevented AF. Collectively, our results 
indicate that alterations of RyR2 and mitochondrial ROS generation form a vicious cycle in the 
development of AF. Targeting this previously unrecognized mechanism could be useful in developing 
effective interventions to prevent and treat AF.
Atrial fibrillation (AF), the most common cardiac arrhythmia, has high morbidity and mortality in 
adults1,2. Despite intense research for over 100 years, AF remains incompletely understood and treatment 
is challenging3–8. AF can be associated with structural and electrical remodeling of the cardiac atria4,6,8,9. 
Structural changes may directly or indirectly induce atrial electric abnormalities leading to atrial ectopic 
events and AF. However, it has been difficult to distinguish whether structural changes are the cause 
or the consequence of AF. In fact, AF has been shown to occur in individuals with structurally normal 
hearts including those with catecholaminergic polymorphic ventricular tachycardia (CPVT)10,11 which 
is linked to inherited mutations in the intracellular Ca2+ release channel/ryanodine receptor (RyR2) 
that cause intracellular Ca2+ leak12–14. Altered intracellular Ca2+ homeostasis has been associated with 
the pathogenesis of AF. In atrial myocytes, type 2 RyR (RyR2) is the major intracellular Ca2+ release 
channel14, and RyR2 dysfunction can affect cellular electric activity. Atrial myocytes from both patients 
and animals with AF display increased diastolic SR Ca2+ leak via RyR215,16. Moreover, we and others 
have reported that AF can be induced in knock-in mice harboring specific mutations in RyR2, leading 
to intracellular Ca2+ leak17–19. Recently, a report revealed that AF occurred in a 2-year-old child with a 
CPVT linked RyR2 mutation11. These reports indicate that RyR2 dysfunction may be a critical contrib-
utor to AF.
Oxidative stress has been associated with the development of AF both in patients and animal models 
of AF20–24, and antioxidant drugs have shown beneficial effects on AF development21,23,24. Furthermore, 
the prevalence of AF increases with age and the age-dependent increase in oxidative damage is widely 
acknowledged25,26. However, the molecular mechanisms underlying oxidative stress in the development 
of AF remain essentially unclear. RyR2 is an important molecular target of oxidative stress in cardiac 
myocytes14. While stress-induced oxidation of RyR2 in ventricular myocytes has been associated with 
cardiovascular disease14,27–30, little is known about the pathophysiological role of atrial RyR2 oxidation. 
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In a previous report we demonstrated that RyR2 is oxidized in atrial myocytes from a murine model of 
CPVT, RyR2-R2474S+/– mice, that display substantial increased AF susceptibility17.
In the present study, we explored the mechanistic role of atrial RyR2 oxidation in the pathophysiology 
of AF in two murine models of RyR2-mediated intracellular Ca2+ leak: mice harboring an RyR2 mutation 
linked to human CPVT (RyR2-R2474S+/–) and mice expressing a phosphomimetic aspartic acid residue 
at position 2808 (RyR2-S2808D+/+) leading to constitutively leaky channels. Moreover, we evaluated the 
role of mitochondrial free radicals on RyR2 oxidation by crossing mice harboring RyR2 mutations asso-
ciated with Ca2+ leak with mice overexpressing human catalase targeted to mitochondria (mCAT mice).
Results
Atrial RyR2 Oxidation and Leak in Atrial Fibrillation. Atrial RyR2s from patients with chronic AF 
were oxidized, phosphorylated and depleted of calstabin 2 (a subunit of the complex that stabilizes the 
closed state of RyR2 during diastole14,31) compared to subjects in sinus rhythm (Fig. 1a–d). These results 
are consistent with our previous report in mice harboring CPVT-mutated RyR2 channels, where RyR2 
channels were oxidized and DTT treatment reduced SR Ca2+ leak in atrial myocytes17.
To explore the role of intracellular Ca2+ leak via RyR2 in the development of AF, we used a trans-
genic mouse harboring a constitutively leaky RyR2 channel (RyR2-S2808D+/+), which displays an 
age-related RyR2 oxidation in ventricular myocytes32. WT and RyR2-S2808D+/+ littermates were divided 
into three different age groups (3-, 6- and 9-month old). Similar to ventricular RyR2, atrial RyR2 from 
RyR2-S2808D+/+ mice exhibited age-related oxidation and depletion of calstabin 2 compared to RyR2 
Figure 1. Increased oxidation of the atrial RyR2 complex in patients with AF and in RyR2-S2808D+/+ 
mice. (a) post-translational modifications of the RyR2 complex in right atrial (RA) tissue of patients 
with AF and normal ventricular function or controls. RA appendage tissue was obtained at the time 
of cardiac surgery from patients with chronic AF (> 6 months; n = 10), and patients in sinus rhythm 
(n = 10). To determine RyR2 channel oxidation, the carbonyl groups in the protein side chains of 
immunoprecipitated RyR2 were derivatized to (DNP) by reaction with 2,4-dinitrophenylhydrazine. The DNP 
(2,4-dinitrophenylhydrazone) signal associated with RyR2 was determined by anti-DNP antibody. (b–d), 
Quantification of DNP signal (b), PKA hyperphosphorylation (c), and calstabin 2 bound to RyR2 (d) in 
human atrial samples. *p < 0.01 vs control. Error bars represent s.e.m. (e) Post-translational modifications 
of the RyR2 complex in atrial samples from WT and RyR2-S2808D+/+ mice. (f) and (g), Quantification of 
DNP signal (f) and calstabin 2 bound to RyR2 (g); atrial samples were obtained from at least 5 mice in each 
group. AU: arbitrary units. All data are shown as mean  ±  s.e.m. * and **: p < 0.05 and 0.01 vs 3-month-old 
group; #: p < 0.05 vs WT.
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from WT mice which displayed no PKA phosphorylation of RyR2 at 3-, 6- and 9-months of age (Fig. 
1e–g, Supplementary Figure 1). To measure intracellular Ca2+ leak and its effects we examined Ca2+ 
spark frequency and SR Ca2+ load. At 3 months of age there was no significant difference in Ca2+ spark 
frequency (Ca2+ sparks/100 μ m/s: 3.80 ± 0.47 in S2808D vs. 3.69 ± 0.31 in WT, n.s.) and SR Ca2+ load 
(∆F/F0: 10.43 ± 0.59 in S2808D vs. 10.78 ± 0.33 in WT, n.s.) in atrial myocytes isolated from WT versus 
RyR2-S2808D+/+ mice (Fig. 2a–d). In contrast, at 6 months of age atrial myocytes from RyR2-S2808D+/+ 
mice displayed significantly higher Ca2+ spark frequencies (Ca2+ sparks/100 μ m/s: 6.13 ± 0.42 vs. 
3.39 ± 0.38 in WT, p < 0.01) and markedly depleted SR Ca2+ stores (∆F/F0: 8.86 ± 0.37 vs. 10.56 ± 0.27 
Figure 2. Age-dependent increases in SR Ca2+ leak in atrial myocytes correlate with AF susceptibility 
in RyR2-S2808D+/+ mice. (a) Representative Ca2+ sparks images in atrial myocytes from WT and RyR2-
S2808D+/+ mice. (b) Ca2+ spark frequencies in atrial myocytes from WT and RyR2-S2808D+/+ mice with 
the indicated ages, n = 50~60 cells from 3 ~ 4 mice in each group. (c) Representative trace of caffeine-
induced (10 mM, red triangles) Ca2+ transients immediately following 1-Hz field stimulation in atrial 
myocytes from WT (left) and RyR2-S2808D+/+ (right) mice; ‘mo’ = months. (d) SR Ca2+ load in atrial 
myocytes from WT and RyR2-S2808D+/+ mice at the indicated ages, n = 25 ~ 28 cells from 3 ~ 4 mice in 
each group. (e) Representative surface ECG traces of intra-esophageal burst pacing-induced AF in 9-month-
old RyR2-S2808D+/+ mice. Upper panel shows ECG trace before pacing and lower panel shows ECG 
following termination of burst pacing. Red triangles indicate P waves and red lines indicate QRS complexes, 
consistent with normal sinus rhythm. Lower panel shows irregular rhythm; blue lines indicate burst pacing 
currents. (f) Prevalence of AF during intra-esophageal burst pacing in WT and RyR2-S2808D+/+ mice at 
different ages. All data are shown as mean ± s.e.m. * and **: p < 0.05 and 0.01 vs WT; #, ##: p < 0.05 and 0.01 
vs 3-month-old; $: p < 0.05 vs 6-month-old.
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in WT, p < 0.05), consistent with age-related intracellular Ca2+ leak, compared with WT littermates 
(Fig.  2a–d). These differences were further increased in 9-month-old mice (Ca2+ sparks/100 μ m/s: 
8.00 ± 0.45 in S2808D vs. 3.93 ± 0.40 in WT, p < 0.01; SR Ca2+ load (∆F/F0: 7.93 ± 0.51 in S2808D 
vs. 10.93 ± 0.64 in WT, p < 0.01) as shown in Fig.  2A–D. Despite the observed depletion of SR Ca2+ 
stores, there was no significant change in the paced Ca2+ transient amplitude (Supplementary Figure 
2a). This is most likely attributable to the increased fractional release of Ca2+ (Supplementary Figure 2b) 
due to a leftward shift in the Ca2+–sensitivity to activation of RyR2. Consistent with the increased SR 
Ca2+ leak in atrial myocytes, ex vivo confocal imaging in intact hearts18,33 and in vitro confocal imag-
ing in isolated atrial myocytes revealed increased intracellular arrhythmic Ca2+ activity in the atria of 
9-month-old RyR2-S2808D+/+ mice compared to WT littermates (Supplementary Figures 3–4). Similar 
to RyR2-R2474S+/– mice17, the SR Ca2+ leak observed in atrial myocytes isolated from 9-month-old 
RyR2-S2808D+/+ mice was reduced by either 2-hour treatment with the Rycal S107 (10 μ M), which 
prevented the oxidation-induced dissociation of calstabin 2 from RyR2, or treatment with the reducing 
agent dithiothreitol (DTT, Supplementary Figure 5a). CaMKII-mediated RyR2 phosphorylation has been 
recently reported to be involved in AF34. However, KN-93 (1 μ M), a CaMK inhibitor35, did not signif-
icantly reduce the SR Ca2+ leak in atrial myocytes from RyR2-S2808D+/+ and RyR2-R2474S+/– mice 
(Supplementary Figure 5).
Age-dependent increase of AF susceptibility in RyR2-S2808D+/+ mice. AF can be linked to intra-
cellular arrhythmic Ca2+ activity in atrial myocytes18. To investigate AF susceptibility in RyR2-S2808D+/+ 
mice we induced AF by pacing the left atrium via an endo-esophageal pacing catheter. At baseline, all 
mice were in normal sinus rhythm (Fig. 2e). Upon pacing, RyR2-S2808D+/+ mice exhibited a progressive, 
age-related augmented susceptibility to AF in response to atrial burst pacing measured as the percentage 
of mice with pacing induced AF: 9.7% (3/31) at 3 months; 45.8% (11/24) at 6 months; and 68.4% (13/19) 
at 9 months). In contrast AF was rarely inducible in WT mice at the same ages: 5.6% (2/36); 5.0% (1/20); 
and 10.5% (2/19) at 3, 6 and 9 months of age, respectively (Fig. 2f).
AF has also been associated with structural remodeling of the atria4,6,7,9. However, histological anal-
yses of atrial tissue did not show any obvious structural abnormality in 9-month-old RyR2-S2808D+/+ 
mice (Supplementary Figure 6), suggesting that the altered Ca2+ homeostasis is the main factor contrib-
uting to AF in this mouse model. Moreover, a 2-week pharmacological treatment with a stabilizer14,18 of 
the closed state of RyR2 channel (S107, 40 mg/kg/d in drinking water) prevented the development of AF 
in 9-month-old RyR2-S2808D+/+ mice (Supplementary Figure 7).
Increased intracellular oxidative stress in atrial myocytes from RyR2-S2808D+/+ mice. 
Reactive oxygen species (ROS) production measured using the fluorescent indicator H2DCFDA was 
significantly increased in freshly isolated atrial myocytes from 6- and 9- month old RyR2-S2808D+/+ 
mice, indicating increased oxidative stress (Fig. 3a). Mitochondria are the major source of intracellular 
ROS36,37. MitoSOX Red revealed that atrial myocytes from 6- and 9-month old RyR2-S2808D+/+ mice 
had significantly higher mitochondrial ROS level (Fig. 3b). Additionally, ultrastructural analyses revealed 
profound mitochondrial dysmorphology, including lamellar degeneration, outer membrane disruption 
Figure 3. Increased intracellular oxidative stress and mitochondrial ROS levels in WT and RyR2-
S2808D+/+ mice. (a) atrial intracellular oxidative stress measured by CM-H2DCFDA, n > 100 cells from 
3 ~ 4 mice in each group. (b) mitochondrial ROS levels in atrial myocytes, n > 140 cells from 3 ~ 4 mice in 
each group. The DCF and mitoSOX fluorescence are normalized to fold of 3-month-old WT group. All data 
are shown as mean ± s.e.m. * and **: p < 0.05 and 0.01 vs 3-month-old group; #, ##: p < 0.05 and 0.01 vs WT.
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and swelling, in atria from 9-month old RyR2-S2808D+/+ mice, compared with age-matched WT litter-
mates (Fig. 4a–c).
Genetic inhibition of mitochondrial ROS production reduces AF. To further investigate the role 
of mitochondrial ROS in atrial RyR2 dysfunction we crossed RyR2-S2808D+/+ mice with transgenic 
mice (mCAT) overexpressing the human catalase gene targeted to mitochondria to decrease mitochon-
drial ROS production. RyR2-S2808D+/+/mCAT mice exhibited significantly reduced atrial mitochondrial 
abnormalities (Fig. 4a–c). In atrial myocytes isolated from 9-month old RyR2-S2808D+/+/mCAT mice, 
both cellular and mitochondrial oxidative stress were markedly reduced compared with age-matched 
RyR2-S2808D+/+ littermates (Fig. 4d–e). Strikingly, blunted ROS production was associated with reduced 
Figure 4. Genetic reduction of mitochondrial ROS levels prevents mitochondrial dysmorphology, atrial 
SR Ca2+ leak and AF in 9-month-old RyR2-S2808D+/+ mice. (a) Representative transmission electron 
micrographs of atrial mitochondria from WT, RyR2-S2808D+/+, mCAT, and RyR2-S2808D+/+/mCAT+ 
mice. n = 3/group, 20000 × magnification, scale bar: 1 μm. (b) and (c) Morphometric analysis of atrial 
mitochondria reveals abnormalities in RyR2-S2808D mice. Abnormal mitochondria were defined by the 
loss of electron density in more than 20% of the area of a mitochondrion. The relative number of damaged 
mitochondria was quantified by blinded observers from at least 20 images from different fields of atrial 
samples. The dense core granules represent the atrial specific granules, considered the storage site of atrial 
natriuretic peptide. (d) and (e) Assessment of intracellular oxidative stress (d) and mitochondrial ROS level 
(e) in atrial myocytes. n > 100 cells from 3 mice in each group, the DCF and mitoSOX fluorescence are 
normalized to fold of WT group. (f) Representative surface ECG traces from indicated mice during intra-
esophageal burst pacing. (g) Prevalence of AF in WT (n = 11), RyR2-S2808D+/+ (n = 11), mCAT (n = 12), 
and RyR2-S2808D+/+/mCAT+ (n = 23) mice. (h) Ca2+ sparks frequencies in atrial myocytes isolated from 
mice in these groups, n = 40 ~ 47 cells from at least 3 mice in each group. All mice were 9-months-old. 
All data are shown as mean ± s.e.m. * and **: p < 0.05 and 0.01 vs WT; #, ##: p < 0.05 and 0.01 vs RyR2-
S2808D+/+.
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atrial RyR2 oxidation and castabin2 dissociation resulting in decreased atrial diastolic SR Ca2+ leak and 
AF susceptibility (Fig. 4f–h and Supplementary Figure 8-9).
S107 improves mitochondrial function. To test the hypothesis that atrial mitochondrial dysfunc-
tion is attributable to SR Ca2+ leak, we examined the effects of S107 treatment on atrial mitochondria of 
RyR2-S2808D+/+ mice. Following a 2-month treatment with S107 (40 mg/kg/d in the drinking water), 
both mitochondrial dysmorphology (Fig. 5a–c) and ROS production (Fig. 5d) were significantly reduced 
in 9-month-old RyR2-S2808D+/+ mice compared with vehicle group.
Genetic inhibition of mitochondrial ROS prevents AF. RyR2-R2474S+/– mice display oxidized 
atrial RyR2 and AF susceptibility17 and increased mitochondrial ROS level (Supplementary Figure 10). 
Both mitochondrial ROS levels and intracellular oxidative stress were greatly reduced in RyR2-R2474S+/–/
mCAT mice compared with RyR2-R2474S+/– mice (Fig.  6a–b). Similarly, crossing RyR2-R2474S+/– 
with mCAT mice significantly decreased the intracellular Ca2+ leak in atrial myocytes compared to 
RyR2-R2474S+/– mice (Fig.  6c). Importantly, AF susceptibility in RyR2-R2474S+/–/mCAT was dimin-
ished to 22.2% (4/18) compared with 65.0% (13/20) in RyR2-R2474S+/– mice (Fig. 6d–e).
Discussion
Accumulating evidence suggests that oxidative stress plays a pivotal role in the development and per-
petuation of AF20–22,38,39. Our present findings strongly support previous reports suggesting that AF is 
associated with myocardial oxidative stress20,38.
Figure 5. Inhibition of SR Ca2+ leak attenuates mitochondrial ROS production and dysfunction. (a) 
Representative transmission electron micrographs of atrial mitochondria from 9-month-old RyR2-S2808D+/+ 
mice with 2-month S107 or vehicle treatment. n = 3/group, 20000 × magnification, scale bar: 1 μm. (b) and 
(c) Morphometric analyses of atrial mitochondria show attenuated abnormalities in S107 treated group. (d) 
mitochondrial ROS levels in atrial myocytes from 9-month-old RyR2-S2808D+/+ mice following a 2-month 
treatment with S107 or vehicle. n > 100 cells from each group, the mitoSOX fluorescence are normalized to 
fold of S107 group. All data are shown as mean ± s.e.m. * and **: p < 0.05 and 0.01 vs vehicle.
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We and others have proposed that atrial diastolic SR Ca2+ leak is an essential contributing factor in 
the pathogenesis of AF17–19. Diastolic SR Ca2+ leak due to RyR2 dysfunction may be linked to multiple 
factors including phosphorylation, oxidation or pathological mutations of RyR2, all of which can result 
in channel dysfunction14. We have previously reported PKA hyperphosphorylation and calstabin2 dis-
sociation from RyR2 in several models of chronic AF15. We have also demonstrated that chronic PKA 
phosphorylation of ventricular RyR2 is associated with oxidation of the channel and the combination of 
PKA phosphorylation and oxidation of RyR2 results in significantly more calstabin 2 dissociation from 
RyR2 compared to each post-translational modification alone27. This observation is consistent with our 
present results, indicating the importance of oxidation of atrial RyR2 in promoting AF. Furthermore, 
oxidation of atrial RyR2 has been shown to be a key contributor to diastolic SR Ca2+ leak and AF in 
animal models of CPVT17.
It has been reported that CaMKII is also a molecular target of oxidative stress, and that oxidized 
CaMKII can phosphorylate RyR2 at Ser2814 inducing intracellular Ca2+ leak40. However, we found that 
KN-93 treatment did not reduce atrial SR Ca2+ leak in RyR2-S2808D+/+ or RyR2-R2474S+/− atrial cardi-
omyocytes, suggesting that direct oxidation of atrial RyR2, but not phosphorylation by oxidized CaMKII, 
is the main factor inducing atrial SR Ca2+ leak and AF.
The importance of PKA phosphorylation in cardiac disease has been challenged by Valdivia’s group, 
who concluded that phosphorylation of Ser2808 plays no role in β -adrenergic cardiac response. The fact 
that our findings have been confirmed by multiple other groups is addressed in a recent review32.
Multiple sources of ROS, including mitochondria, NADPH oxidases and NOS uncoupling, contribute 
to AF5,8,41. Intriguingly, recent reports indicate that atrial sources of ROS vary with the duration and the 
substrate of AF42, and mitochondria have been proposed as the major ROS source for long-term AF and 
age-related functional decline25. This view is consistent with our results showing that mitochondrial ROS 
promote age-related AF.
In the present study we establish for the first time that atrial RyR2 is a specific molecular target of 
oxidative stress that is fundamental in the development of AF. We demonstrate the functional importance 
of RyR2 oxidation in AF pathophysiology, showing that mitochondrial-derived ROS oxidize RyR2 in 
atrial myocytes leading to increased intracellular Ca2+ leak. Importantly, reducing mitochondrial ROS 
production attenuates atrial diastolic SR Ca2+ leak and prevents AF.
Mitochondria have been reported to be abnormal in the atrial tissue of patients with AF39,43. In 
this study, mice harboring leaky RyR2 also display mitochondrial abnormalities and increased ROS 
Figure 6. Genetic reduction of mitochondrial ROS levels prevents atrial SR Ca2+ leak and AF in RyR2-
R2474S+/– mice. (a–c), mitochondrial ROS levels (a), intracellular oxidative stress (b) and SR Ca2+ leak 
(c) in atrial myocytes from 3-month-old RyR2-R2474S+/– and RyR2-R2474S+/–/mCAT mice. For A and 
B, n > 100 cells from each group, the DCF and mitoSOX fluorescence are normalized to fold of R2474S x 
mCAT group. For C, n = 40 cells from 5 mice in each group. (d) Representative surface ECG traces from 
indicated mice following intra-esophageal burst pacing. (e) Prevalence of AF in RyR2-R2474S+/– (n = 20) 
and RyR2-R2474S+/–/mCAT+ (n = 18) mice. All data are shown as mean ± s.e.m. * and **: p < 0.05 and 0.01.
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production. In cardiac myocytes, mitochondria and the SR are co-localized in the ‘mitochondrial micro-
domain44’. Since mitochondrial Ca2+ uptake via the mitochondrial Ca2+ uniporter is dependent on SR 
Ca2+ release44–46, alterations in SR Ca2+ release can also affect mitochondrial function by regulating mito-
chondrial Ca2+ uptake44,47. In atrial myocytes isolated from RyR2-S2808D+/+ mice, leaky RyR2 channels 
were associated with an age-related increase in diastolic SR Ca2+ release without any significant change 
in the systolic Ca2+ transient amplitudes. Pharmacological inhibition of RyR2 Ca2+ leak restored atrial 
mitochondrial morphology and function suggesting that mitochondrial Ca2+ overload plays a key role 
in AF pathophysiology.
Taken together, our data demonstrate that RyR2 oxidation resulting from intracellular oxidative stress 
in atrial myocytes leads to increased SR Ca2+ leak contributing to the pathogenesis of AF. Alterations 
of RyR2 inducing intracellular Ca2+ leak, including constitutive PKA phosphorylation or CPVT muta-
tions, trigger a vicious cycle, in which SR Ca2+ leak in atrial myocytes impairs mitochondrial function 
leading to an increase in ROS production, thereby promoting RyR2 oxidation and further Ca2+ leak. 
Pharmacological targeting of leaky RyR2 channels or genetically inhibiting mitochondrial ROS produc-
tion prevents AF providing mechanistic insights that could lead to new therapeutic targets for AF.
Methods
Human studies. All human analyses were performed in accordance with protocols approved by 
the Institutional Review Board of the New York Presbyterian Hospital and by the Ethics Committee of 
Columbia University. Written informed consent was obtained from all participants. RA appendage tissue 
was obtained at the time of cardiac surgery from patients with chronic AF (> 6 months; n = 10), and 
patients in sinus rhythm (n = 10).
Animal studies. All animal experiments were performed in accordance with NIH Guidelines for the 
Care and Use of Laboratory Animals, and animal protocols were approved by the Institutional Animal 
Care and Use Committee (IACUC) of Columbia University.
Generation of the mCAT mouse has been described previously48. RyR2-R2474S+/- and RyR2-S2808D+/+ 
mice were generated as described17,45. All mice were backcrossed into the C57BL/6 background for > 10 
generations. All in vivo and in vitro experiments were conducted by operators who were blinded to the 
genotypes of the mice.
S107 treatment. For in vitro experiments using isolated atrial myocytes, 10 μ M S107 was added 
to the extracellular solution for 2 hours. For in vivo experiments, S107 was diluted in drinking water 
at 0.25 mg/ml (40 mg/kg/d). No differences were detected in water consumption between vehicle and 
S107-treated groups.
Intra-esophageal burst pacing in mouse. Intra-esophageal pacing was performed by placing in the 
esophagus, close to the left atrium, a 1.1-Fr octapolar catheter (EPR-800, Millar Instruments, Houston, 
Texas) connected to an external stimulator (STG-3008, MultiChannel Systems, Reutlingen, Germany). 
A computerized data acquisition system (EMKA Technologies, Falls Church, VA) was used to record 
a 3-lead surface ECG, and up to 4 intra-esophageal bipolar electrocardiograms. Inducibility of atrial 
arrhythmias was tested by applying a series of 2-second bursts. The first 2-second burst had a cycle length 
(CL) of 40 ms; then the CL was progressively decreased by 2 ms in each successive burst until reaching 
10 ms. AF was defined as a period of rapid irregular atrial rhythm lasting at least 1 sec.
Isolation of adult murine atrial myocytes. Adult murine atrial myocytes were isolated as fol-
lows. The heart was rapidly isolated, cannulated and perfused with AfCS perfusion buffer, comprised of 
(in mM): NaCl 113, KCl 4.7, KH2PO4 0.6, Na2HPO4 0.6, MgSO4 1.2, NaHCO3 12, KHCO3 10, HEPES 
10, taurine 30, glucose 1.5 and 2,3-Butanedione 2-monoxime (BDM) 10, for 5 minutes at a speed of 
3 ml/min. Then, perfusion was switched to ‘digestion buffer’ (which includes 0.65 mg/mL type 2 colla-
genase and 50 μ M CaCl2 in AfCS) and perfused for 10–15 minutes. Atria were cut and teased into small 
pieces in ‘stop 1’ buffer (0.65 mg/mL type 2 collagenase, 0.065 mg/mL Protease XIV, 15 mg/mL BSA 
and 50 μ M CaCl2 in AfCS) and bathed at 37 °C for 10 minutes after which the enzyme was removed by 
centrifugation (4 min at 200 rpm). The cells were then resuspended in ‘stop 2’ buffer (15 mg/mL bovine 
serum albumin and 50 μ M CaCl2 in AfCS) and gradually recovered to a final [Ca2+] of 1.8 mM.
Ca2+ imaging in isolated atrial myocytes. To measure intracellular Ca2+, cells were loaded with 
5 μ M Fluo-4 AM (ThermoFisher Scientific, Waltham, MA) for 20 minutes and washed three times and 
maintained in the following solution (in mM): NaCl 125, KCl 4.75, MgSO4 1.2, KH2PO4 1.2, HEPES 30, 
glucose 10, taurine 50, CaCl2 2 and pH = 7.4. A Leica TCS SP2 confocal microscopy with 40x, 1.25 NA 
oil immersion objectives was used for linescan imaging. The scan zoom was adjusted to fit the cells, 
and scan line was performed along the long axis of cells49. The excitation for Fluo-4 was 488 nm, while 
emission was collected at 505–530 nm. For Ca2+ sparks recording, cells were scanned at 400 Hz for 20 s 
following 1 minute of pacing at 3 Hz. Ca2+ sparks detection and analysis was performed as previously 
described49–51. KN-93 was purchased from Sigma-Aldrich (St. Louis, MO). For simultaneous recording 
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of Ca2+ transient amplitudes and SR Ca2+ contents, cells were exposed to 10 mM caffeine immediately 
following termination of pacing at 1 Hz for 1 minute. Sampling started 10 s before caffeine treatment.
Measurements of intracellular oxidative stress. For the evaluation of intracellular oxidative 
stress, cells were pre-incubated with the chloromethyl derivative CM-H2DCFDA (10 μ M, ThermoFisher 
Scientific) for 30 minutes and washed. Fluorescence intensity and images were obtained using a confocal 
microscope (Zeiss 5 Live, 40 x oil immersion lens). Excitation was at 488 nm, and emission was collected 
at 505–530 nm. Since CM-H2DCFDA is light sensitive and oxidized progressively, we used the same 
scanning parameters for all experiments. For each dish, images were rapidly acquired for ~10 randomly 
selected cells. More than 100 cells per group were examined for intracellular fluorescent intensities.
Mitochondrial ROS detection. For mitochondrial ROS detection, cells were incubated for 20 min 
with 5 μ M MitoSOX Red (Invitrogen/Molecular probes) and washed. Fluorescence intensity and images 
were obtained using confocal microscopy (Zeiss 5 Live, 40x oil immersion lens). MitoSOX Red was 
excited at 488 nm and emission was collected at 540–625 nm. The scanning parameters were unchanged 
for all the scans. For each group, fluorescence intensities of > 100 cells randomly selected from several 
different dishes were examined.
Immunoprecipitation and immunoblotting analysis of RyR modifications. RyR2 was immu-
noprecipitated from atrial homogenates (250 μ g) using anti-RyR antibody in 0.5 ml of a modified RIPA 
buffer (50 mM Tris-HCl pH 7.4, 0.9% NaCl, 5.0 mM NaF, 1.0 mM Na3VO4, 0.5% Triton-X100, and protease 
inhibitors) overnight at 4 °C. The samples were incubated with protein A sepharose beads (Amersham 
Pharmacia Biotech, Piscataway, NJ) at 4 °C for 1 hr and washed five times with 1.0 ml RIPA. Samples 
were heated to 95 °C and size fractionated by PAGE (6% for RyR2, 15% for calstabin 2). Levels of RyR2 
bound proteins were normalized to the total RyR2 immunoprecipitated. All immunoblots were devel-
oped using the Odyssey system (LI-COR, Inc., Lincoln, NE) with IR labeled anti-mouse and anti-Rabbit 
IgG (1:10000 dilution) secondary antibodies52. To detect RyR2 protein oxidation, atrial SR membrane 
samples (50 ug) were immunoprecipitated as described above. Immunoprecipitates were treated with 
2, 4-dinitrophenylhydrazine (DNP) and the derivatized carbonyls were detected using an OxyBlotTM 
Protein Oxidation Detection Kit (Cat # S7150, Chemicon International, Inc., Temecula, CA)45,49. Proteins 
were size fractionated on 6% SDS-PAGE gels and transferred onto nitrocellulose membranes and immu-
noblots were developed with an anti-RyR antibody (Affinity Bioreagents, Bolder, CO, 1:2,000). The DNP 
signal associated with RyR was determined using an anti-DNP antibody (1:2000)45.
Transmission Electron Microscopy. Atria were fixed in 2.5% glutaraldehyde in 0.1 M Sørensen’s 
buffer and post-fixed in 1% OsO4. Following dehydration, samples were embedded in Lx-112 (Ladd 
Research Industries, Williston, VT). After cutting (ultramicrotome MT-7000), the 60 nm sections were 
stained with uranyl-acetate and lead-citrate and visualized (JEM-1200 EXII, JEOL, Tokyo, Japan), as 
previously described45,49. For each animal at least twenty randomly selected sections were used for the 
analysis of mitochondrial morphology.
Statistical analysis. All results are presented as mean  ±  s.e.m. Statistical analyses were performed 
using the unpaired Student’s t test (for 2 groups) and one-way ANOVA with Bonferroni post hoc cor-
rection (for groups of 3 or more) unless otherwise indicated. P < 0.05 was considered to be statistically 
significant.
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Supplementary Figure 1. Lack of PKA phosphorylation of atrial RyR2 in 
control WT mice at 3, 6 and 9 months of age (A) compared with WT PKA 
treated samples as control. (B) Quantification of data represented in (A). Atrial 
samples were obtained from at least 5 mice in each group. Data are shown as 






Supplementary Figure 2. Increased fractional release of SR Ca2+ in RyR2-
S2808D cardiac myocytes indicating that chronic PKA phosphorylation of 
RyR2 can result in maintained SR Ca2+ release despite reduced SR Ca load 
due to increased fractional release of SR Ca2+ due to leaftward shift in the 
sensitivity of cytosolic Ca2+ induced activation of RyR2. Ca2+ transients (A) 
amplitude and SR fractional Ca2+ release (B) in atrial myocytes from WT and 
RyR2-S2808D+/+ mice at the indicated ages. n=20~28 cells from ≥3 mice in each 





Supplementary Figure 3. Increased atrial Ca2+ alternans and Ca2+ waves in 
intact hearts from 9-month-old RyR2-S2808D+/+ mice compared to WT 
controls. 
A, Representative images of 10 Hz pacing-induced Ca2+ alternans in right atrial 
tissue from 9-month-old WT and RyR2-S2808D+/+ mice. B, Quantification of atrial 
Ca2+ alternans in the indicated groups. C, Atrial Ca2+ waves in the indicated 
groups. Hearts were perfused with 4 mM [Ca2+] to induce Ca2+ waves. n=at least 
6 hearts in each group. All Data are shown as mean ± s.e.m. * and **, p<0.05 




Supplementary Figure 4. Increased spontaneous Ca2+ transients in atrial 
myocytes from 9-month-old RyR2-S2808D+/+ mice. Linescan Ca2+ images (A) 
and quantification of Ca2+ transients (B). Atrial myocytes were bathed in 2 mM 
[Ca2+] imaging buffer upon 1.5 Hz-pacing during imaging. n=32~50 cells from at 
least 3 mice in each group. Data are shown as mean ± s.e.m. *, p<0.05 vs WT; #, 




Supplementary Figure 5. Increased Ca2+ sparks frequencies in atrial 
myocytes from 9-month-old RyR2-S2808D+/+ mice are reduced by S107 or 
DTT but not by KN-93. (A) and 3-month-old RyR2-R2474S+/- mice (B). Atrial 
myocytes were treated by S107 (10 µM), DTT (1 mM), or KN-93 (1 µM); n=33~52 
cells in each group. Data are shown as mean ± s.e.m. **, p<0.01 vs vehicle. 
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Supplementary Figure 6. Histologic examination revealed no structural 
differences between atria from 9-month-old WT and RyR2-S2808D+/+ mice. 
A, Representative Masson’s trichrome stained sections of atria from 9-month-old 
WT and RyR2-S2808D+/+ mice; scale bar: 100 µm. B, Bar graph showing the 
quantification of fibrosis in atrial tissue. Data are shown as mean ± s.e.m.  
 8	  
 
Supplementary Figure 7. Two-week treatment with S107 in the drinking 
water prevents AF in 9-month-old RyR2-S2808D+/+ mice. 
A, Representative surface ECG traces from 9-month-old RyR2-S2808D+/+ mice 
following intra-esophageal burst pacing in vehicle (upper) and S107-treated 
(lower) groups. B, Bar graph showing the prevalence of AF following intra-
esophageal burst pacing in vehicle and S107 group, n=15 mice per group. *, 




Supplementary Figure 8. A, Post-translational modifications of the RyR2 
complex in atrial samples from 9-month-old WT, RyR2-S2808D+/+ and RyR2-
S2808D+/+/mCAT+ mice.  B-C, Quantification of DNP signal (B) and calstabin 2 
bound to RyR2 (C); atrial samples were obtained from at least 5 mice in each 
group. AU: arbitrary units. All data are shown as mean ± s.e.m. *, p<0.05 vs WT; 







Supplementary Figure 9. Decreased SR Ca2+ load in atrial myocytes from 9-
month-old RyR2-S2808D+/+,mice compared to WT mCAT and RyR2-
S2808D+/+/mCAT+ mice. n=20~22 cells from ≥3 mice in each group. Data are 





Supplementary Figure 10. Mitochondrial ROS level increased in atrial 
myocytes from RyR2-R2474S+/- mice compared to WT mice. n=30 cells from 
≥2 mice in each group. Data are shown as mean ± s.e.m. *, p<0.05 vs WT. 
	  
